<unk>  is an immune modulator that is FDA approved for the {{{indicationType}}} of adult rheumatoid arthritis (RA), juvenile idiopathic arthritis.   Common adverse reactions include headache, upper respiratory tract infection, nasopharyngitis, and nausea.
Abatacept
Belatacept
Atezolizumab
Risankizumab
Adalimumab
Ocrelizumab
Efalizumab
Glatiramer